Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Steven D. Harr
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 142
- Beta
- 2.13
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -5.94
Financials
Net Income
$-63.63MEBITDA
$-61.44MFree Cash Flow
$-34.41MEPS (diluted)
$-0.22Shares Outstanding (diluted)
295.67M+86.2%Operating Expenses
$65.42MCash & Debt
$160.49MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-244.17M | $-0.96 |
| 2024 | $0.00 | $-266.76M | $-1.16 |
| 2023 | $0.00 | $-283.25M | $-1.46 |
| 2022 | $0.00 | $-269.48M | $-1.43 |
| 2021 | $0.00 | $-355.93M | $-2.14 |
| 2020 | $0.00 | $-285.31M | $-1.63 |
| 2019 | $0.00 | $-130.78M | $-0.70 |
| 2018 | $0.00 | $-13.25M | $-0.07 |
Valuation
SANAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+50.00%Social Signal Score
Mentions (2)
- Newsseekingalpha.com·5h ago·Positive
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newsglobenewswire.com·9d ago·Negative
Sana Biotechnology to Present at September 2026 Investor Conferences SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update.
View source ↗
Earnings
Thu, Nov 5(in 8 weeks)
Consensus estimate $-0.18 per share
Typical surprise +6.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.22 vs $-0.15miss
- Mon, May 11$-0.14 vs $-0.15beat
- Tue, Mar 3$-0.16 vs $-0.13miss
- Thu, Nov 6$-0.15 vs $-0.18beat
- Mon, Aug 11$-0.39 vs $-0.20miss
- Thu, May 8$-0.20 vs $-0.22beat
Estimates and results for SANA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SANA officers and directors.
- Bought
- —
- Sold
- $1.9m
0 trades
4 trades
- Fmr Llcsold
- Fmr Llcsold
- Fmr Llcsold
- Fmr Llcsold
96 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SANA.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.